Edition:
United States

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

1.76USD
17 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.76
Open
$1.77
Day's High
$1.77
Day's Low
$1.76
Volume
579
Avg. Vol
5,332
52-wk High
$3.10
52-wk Low
$0.80

Chart for

About

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company’s activities are divided into two segments: Human Health and Animal Health. The Human Health segment specializes in ovarian and breast cancer. The Animal Health area focuses on developing cancer... (more)
No analyst recommendations are available for .

Overall

Beta: 1.02
Market Cap(Mil.): kr970.06
Shares Outstanding(Mil.): 179.31
Dividend: --
Yield (%): --

Financials

  OASM.OQ Industry Sector
P/E (TTM): -- 28.29 30.45
EPS (TTM): -0.72 -- --
ROI: -36.57 12.92 12.63
ROE: -36.57 14.94 14.82

BRIEF-Oasmia Pharmaceutical Q3 sales rise, smaller operating loss

* Q3 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 656 COMPARED TO TSEK 36 IN Q3 PREVIOUS YEAR​

Mar 02 2018

Earnings vs. Estimates